A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments

Maria Cristina Maggio

A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Meeting Abstract › peer review

Abstract

Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.

Lingua originale	English
pagine (da-a)	14-14
Numero di pagine	1
Rivista	PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume	18
Stato di pubblicazione	Published - 2020

Altri file e collegamenti

OA Link

Cita questo

@article{c39aa57f3c22472d8ba2dff9352069db,

title = "A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments",

abstract = "Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.",

author = "Maggio, {Maria Cristina}",

year = "2020",

language = "English",

volume = "18",

pages = "14--14",

journal = "Pediatric Rheumatology",

issn = "1546-0096",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments

AU - Maggio, Maria Cristina

PY - 2020

Y1 - 2020

N2 - Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.

AB - Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.

UR - http://hdl.handle.net/10447/464189

M3 - Meeting Abstract

VL - 18

SP - 14

EP - 14

JO - Pediatric Rheumatology

JF - Pediatric Rheumatology

SN - 1546-0096

ER -

A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments

Abstract

Altri file e collegamenti

Fingerprint

Cita questo